Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hardmeier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Der Nervenarzt|September 7, 2006
[Agitation and gamma-hydroxybutyrate]M Hardmeier, M Eichhorn, G Stoppe
Journal of the Neurological Sciences|March 29, 2005
Re: Short-term brain atrophy changes in relapsing-remitting multiple sclerosisM Hardmeier, E W Radue, L Kappos
European Journal of Neurology|July 31, 2007
Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndromeA Becker, M Hardmeier, A J Steck, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 6, 2014
Reliability of fully automated versus visually controlled pre- and post-processing of resting-state EEGF Hatz, M Hardmeier, H Bousleiman, et al.
Journal of Neurology|April 12, 2007
Vertebral artery dissection presenting with fifth cervical root (C5) radiculopathyM Hardmeier, S Haller, A Steck, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
Developmental Cognitive Neuroscience|May 10, 2018
From swing to cane: Sex differences of EEG resting-state temporal patterns during maturation and agingM I Tomescu, T A Rihs, V Rochas, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 22, 2022
Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentialsM Hardmeier, R Schlaeger, A M Lascano, et al.
Clinical Pharmacology and Therapeutics|March 29, 2012
Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteersM Hardmeier, R Zimmermann, S Rüegg, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 22, 2013
Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's diseaseF Hatz, N Benz, M Hardmeier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Nervenarzt|September 7, 2006
[Agitation and gamma-hydroxybutyrate]M Hardmeier, M Eichhorn, G Stoppe
Journal of the Neurological Sciences|March 29, 2005
Re: Short-term brain atrophy changes in relapsing-remitting multiple sclerosisM Hardmeier, E W Radue, L Kappos
European Journal of Neurology|July 31, 2007
Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndromeA Becker, M Hardmeier, A J Steck, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 6, 2014
Reliability of fully automated versus visually controlled pre- and post-processing of resting-state EEGF Hatz, M Hardmeier, H Bousleiman, et al.
Journal of Neurology|April 12, 2007
Vertebral artery dissection presenting with fifth cervical root (C5) radiculopathyM Hardmeier, S Haller, A Steck, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
Developmental Cognitive Neuroscience|May 10, 2018
From swing to cane: Sex differences of EEG resting-state temporal patterns during maturation and agingM I Tomescu, T A Rihs, V Rochas, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 22, 2022
Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentialsM Hardmeier, R Schlaeger, A M Lascano, et al.
Clinical Pharmacology and Therapeutics|March 29, 2012
Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteersM Hardmeier, R Zimmermann, S Rüegg, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 22, 2013
Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's diseaseF Hatz, N Benz, M Hardmeier, et al.
Pageof 2